Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Hematology
•
Pediatric Hematology
What is your criteria for considering oral, or IV, iron repletion in pediatric patients referred to Hematology for restless leg syndrome?
Related Questions
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
What is your standard diagnostic workup to confirm GVHD in a patient post-BMT with skin rash and jaundice?
How do you approach the work-up for a patient with iron deficiency anemia who is not responding to oral iron therapy?
What is your experience with managing patients with STEAP3 mutation and non-transfusion related iron overload?
How do you manage hemophilia A carriers with no history of bleeding complications but with mildly low factor VIII activity (6-40%)?
How do you choose between therapies for newly diagnosed ITP that is refractory to steroids and IVIG?
What is your recommended long term management of extensive dural venous sinus thrombosis in an otherwise healthy young patient?
In patients with lupus nephritis, and MAHA with positive anti-phospholipid autoantibodies, what are the considerations to use or not use anti-coagulation therapy?
How is your experience with point-of-care INR systems for home monitoring of vitamin K antagonists?
How should clinicians approach the decision to use apixaban, or other DOACs, in pediatric patients with acute lymphoblastic leukemia or lymphoma who have additional risk factors for VTE, such as obesity or a family history of thrombosis, given the negative outcome of the PREVAPIX-ALL trial?
